Close



Oct 27, 2023 03:10PM
Sep 25, 2023 08:32AM
Feb 13, 2023 08:25AM
Mar 29, 2022 09:17AM
Dec 20, 2021 07:59AM
Feb 17, 2021 07:32AM
Jan 25, 2019 12:05PM Coherus BioSciences (CHRS) Files Suit Again Amgen (AMGN) Related to Humira Biosimilar
Jan 25, 2019 08:01AM
Nov 2, 2018 01:44PM
Sep 25, 2018 01:41PM
Jul 27, 2018 09:40AM
Jul 18, 2018 09:34AM
Jul 17, 2018 05:58PM
Jul 17, 2018 04:13PM Coherus BioSciences (CHRS) Reports CHMP Outstanding Issues were Satisfactorily Addressed for CHS-1701 Application
Jun 25, 2018 03:34PM
May 23, 2018 05:38AM
May 21, 2018 04:15PM
May 14, 2018 01:40PM
May 14, 2018 12:40PM
May 3, 2018 09:17AM
Jan 5, 2018 04:08PM Coherus BioSciences (CHRS) Receives Scheduling Notice from FDA Related to its CHS-1701 Pegfilgrastim Biosimilar Candidate Granting Type 2 Meeting
Sep 8, 2017 07:51AM
Aug 28, 2017 08:33AM
Aug 21, 2017 08:31AM
Jun 27, 2017 04:09PM
Jun 26, 2017 04:10PM
Jun 14, 2017 09:10AM
Jun 12, 2017 12:03PM Coherus Biosciences (CHRS) PT Lowered to $43 at BMO Capital; 'CHS-1701 CRL Disappointing but Issues Addressable - Buy on Weakness'
Jun 12, 2017 11:33AM
Jun 12, 2017 09:31AM
Jun 12, 2017 06:38AM
May 5, 2017 04:13AM
Apr 25, 2017 08:40AM
Mar 2, 2017 08:31AM
Feb 8, 2017 08:32AM Coherus BioSciences (CHRS) Prices 5.15M Shares at $24.25
Feb 7, 2017 04:05PM
Feb 1, 2017 06:44AM
Jan 31, 2017 03:41PM
Jan 10, 2017 08:47AM
Oct 18, 2016 04:05PM
Oct 7, 2016 05:58AM
Sep 27, 2016 08:02AM Coherus BioSciences (CHRS) Regains All CHS-0214 Development and Commercial Rights from Shire (SHPG)
Sep 6, 2016 05:07PM
Aug 9, 2016 01:55PM
Aug 8, 2016 08:38AM
Jul 11, 2016 01:02PM
Jul 11, 2016 08:32AM
May 26, 2016 03:30PM
Feb 29, 2016 09:46AM Coherus BioSciences (CHRS) Enters $100M Conv. Notes Private Placement
Feb 1, 2016 04:13PM

51,622 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All